Sun Pharma Focuses On Expanding In The Chinese Generic Market

 
• By Akriti Seth

Sun Pharma continues to build its global specialty business with an increasing focus on China and Japan. As it revealed first-quarter results, the company announced a licensing deal with CMS and a new leader for its operations in China.

China_Map
Sun Pharma has linked with local player CMS to target China's generics market • Source: Shutterstock

More from Deals

More from Business